Ansell Ltd (ANSLY)
85.25
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Ansell Enterprise Value: 2.965B for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
September 27, 2024 | 2.965B |
September 26, 2024 | 2.965B |
September 25, 2024 | 2.965B |
September 24, 2024 | 2.965B |
September 23, 2024 | 2.965B |
September 20, 2024 | 2.965B |
September 19, 2024 | 2.965B |
September 18, 2024 | 2.429B |
September 17, 2024 | 2.429B |
September 16, 2024 | 2.429B |
September 13, 2024 | 2.429B |
September 12, 2024 | 2.429B |
September 11, 2024 | 2.429B |
September 10, 2024 | 2.429B |
September 09, 2024 | 2.429B |
September 06, 2024 | 2.429B |
September 05, 2024 | 2.429B |
September 04, 2024 | 2.429B |
September 03, 2024 | 2.429B |
August 30, 2024 | 2.429B |
August 29, 2024 | 2.429B |
August 28, 2024 | 2.429B |
August 27, 2024 | 2.429B |
August 26, 2024 | 2.429B |
August 23, 2024 | 2.429B |
Date | Value |
---|---|
August 22, 2024 | 2.429B |
August 21, 2024 | 2.429B |
August 20, 2024 | 2.429B |
August 19, 2024 | 2.429B |
August 16, 2024 | 2.429B |
August 15, 2024 | 2.429B |
August 14, 2024 | 2.429B |
August 13, 2024 | 2.429B |
August 12, 2024 | 2.429B |
August 09, 2024 | 2.429B |
August 08, 2024 | 2.429B |
August 07, 2024 | 2.429B |
August 06, 2024 | 2.429B |
August 05, 2024 | 2.429B |
August 02, 2024 | 2.429B |
August 01, 2024 | 2.429B |
July 31, 2024 | 2.429B |
July 30, 2024 | 2.429B |
July 29, 2024 | 2.429B |
July 26, 2024 | 2.429B |
July 25, 2024 | 2.429B |
July 24, 2024 | 2.429B |
July 23, 2024 | 2.429B |
July 22, 2024 | 2.429B |
July 19, 2024 | 2.429B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.799B
Minimum
Mar 23 2020
4.440B
Maximum
Jun 29 2021
2.940B
Average
2.736B
Median
Enterprise Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 9.562M |
Immutep Ltd | -- |
Opthea Ltd | 171.85M |
Mesoblast Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | 2.77% |
Operating Earnings Yield | 2.06% |
Normalized Earnings Yield | 2.773 |